Abbott Completes Visiogen Acquisition
Abbott (NYSE: ABT) has completed its acquisition of privately held eye care company Visiogen, expanding the company’s vision care business with a next-generation accommodating intraocular lens (IOL) technology to address presbyopia for cataract patients.
Original Source of Abbott Completes Visiogen Acquisition
